Abstract:The objective of the research was to improve the process design of a combined antisolvent-cooling crystallization to reduce the degree of agglomeration of a real active pharmaceutical ingredient product, which was manufactured using a crystallization stage employing a methanol/water solvent system. Knowledge was gained from the use of process analytical technology (PAT) tools to monitor the process variables, allowing particle size, degree of agglomeration, solute concentration, and supersaturation to be tracked throughout the process. Based on knowledge of the solubility behavior and interpretation of the PAT histories, changes were made to the sequences of antisolvent addition and cooling within the crystallization process to reduce agglomeration in the final product. Different seed loadings and seeding addition points were also investigated to maintain operation within lower supersaturation regions of the phase diagram to limit agglomeration and avoid an undesired polymorphic transformation to an unstable form. The improved sequences of operations and seeding conditions did not provide sufficient improvement in the product quality and so were augmented by applying wet milling for further deagglomeration followed by temperature cycling to remove fine particles generated during milling. Open-loop heating and cooling cycles produced some limited improvements, whereas closed-loop direct nucleation control methods using FBRM as a feedback sensor for particle counts per second were much more successful at producing high-quality crystals of the desired polymorphic form. The work shows that understanding the trajectory of the process through the phase diagram to follow appropriate supersaturation profiles gives improved control of the various kinetic mechanisms and can be used to improve the quality of the final product.

FBRM and PVM Investigations of the Double Feed Semi-Batch Crystallization of 6-Aminopenicillanic Acid

Semibatch RAFT Polymerization for Branched Polyacrylamide Production: Effect of Divinyl Monomer Feeding Policies

Targeting Copolymer Composition Distribution Via Model-Based Monomer Feeding Policy in Semibatch Raft Mini-Emulsion Copolymerization of Styrene and Butyl Acrylate

Monitoring of Antisolvent Crystallization of Sodium Scutellarein by Combined FBRM–PVM–NIR

Kinetics and modeling of semi-batch RAFT copolymerization with hyperbranching

Application of Atomic Force Microscopy in Understanding Crystallization Process

Study on the crystallization process of mevastatin by FBRM

Protein Nucleation and Crystallization Process with Process Analytical Technologies in a Batch Crystallizer

In-Situ Measurement of Particle Length Distribution by FBRM with Application to Needle- or Rod-Shape Crystallization Processes

Process integration for production of 6-aminnopenicillanic acid from penicillin G fermentation broth

Automatic Control of Nucleation and Crystal Growth Using Online Raman Analyzer

A Combined Feeding Strategy for Enhancing Mycophenolic Acid Production by Fed-Batch Fermentation in Penicillium Brevicompactum

Antisolvent crystallization of biapenem: Estimation of growth and nucleation kinetics

Real-time particle size analysis using focused beam reflectance measurement as a process analytical technology tool for continuous microencapsulation process

Pervaporation-assisted Crystallization of Active Pharmaceutical Ingredients (Apis)

Monitoring the Crystallization Process of Methylprednisolone Hemisuccinate (MPHS) from Ethanol Solution by Combined ATR-FTIR- FBRM- PVM

Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization

Membrane-assisted combined cooling and antisolvent crystallization for improved cefuroxime sodium manufacture: From metastable zone analysis to application

Breakage-Facilitated Mixed-Suspension-Mixed-Product-Removal (MSMPR) Crystallization of Pharmaceutical Compounds

Process Analytical Technology (PAT) Aided Identification of Operational Spaces Leading to Tailored Crystal Size Distributions in Azithromycin Crystallization Via Coordinated Cooling and Solution Mediated Phase Transition

Process analytical technology-based (PAT) model simulations of a combined cooling, seeded and antisolvent crystallization of an active pharmaceutical ingredient (API)